Latest Conference Articles

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times Europe® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community

Delving into ancillary testing frequency based on the IRIS registry

Delving into ancillary testing frequency based on the IRIS registry

January 14th 2022, 8:53am

AAO

Dr Ted Leng discusses his presentation, “Variations in Vitreoretinal Physician Utilization of Ancillary Testing: An IRIS Registry Analysis” during Retina Specialty Day at AAO 2021.

Investigating best practices for MicroPulse transscleral therapy for glaucoma

Investigating best practices for MicroPulse transscleral therapy for glaucoma

January 12th 2022, 8:26am

AAO

Robert J. Noecker, MD, MBA, discusses the IRIDEX consensus paper regarding MicroPulse transscleral therapy for glaucoma at AAO 2021.

Bimatoprost implant successfully lowers IOP in Phase 3 of the ARTEMIS study

Bimatoprost implant successfully lowers IOP in Phase 3 of the ARTEMIS study

December 29th 2021, 8:07am

AAO

At AAO, AbbVie presented results from the ARTEMIS study, showcasing IOP lowering that extends beyond the original 20-month timeframe.

Updates on brolucizumab for treatment of wet AMD and DMO

Updates on brolucizumab for treatment of wet AMD and DMO

December 23rd 2021, 8:49am

AAO

Dr Jill Hopkins discusses results from phase 3a of the Merlin trial for brolucizumab as a treatment for wet AMD and provides updates on KESTREL and KITE trials for the treatment of diabetic macular oedema.

Shedding light on antibiotic resistance in ophthalmology with ARMOR study data

Shedding light on antibiotic resistance in ophthalmology with ARMOR study data

December 20th 2021, 8:54am

AAO

At the 2021 American Academy of Ophthalmology annual meeting, Dr Penny Asbell discussed data from the ARMOR study and its effects on treating ophthalmic infections, such as endophthalmitis.

Cell therapy for corneal endothelial disease proves successful in Japan, El Salvador

Cell therapy for corneal endothelial disease proves successful in Japan, El Salvador

December 13th 2021, 8:09am

AAO

New cell therapy drug makes treatment of corneal endothelial disease more accessible.

Phase 1 study results for new sustained-release anti-VEGF formulation, EYP-1901

Phase 1 study results for new sustained-release anti-VEGF formulation, EYP-1901

December 10th 2021, 8:35am

AAO

Dr Jay Duker discusses EYP-1901, EyePoint Pharmaceuticals’ sustained-release anti-VEGF drug for the treatment of wet AMD.

Phase 2b study results of AR-15512 for the treatment of dry eye

Phase 2b study results of AR-15512 for the treatment of dry eye

November 29th 2021, 8:27am

AAO

At AAO 2021, Aerie Pharmaceuticals presented the results of their phase 2b clinical trial of AR-15512, a TRPM8 antagonist, for the treatment of dry eye.

Verana Health's new quality measures dashboard unveiled at AAO 2021

Verana Health's new quality measures dashboard unveiled at AAO 2021

November 23rd 2021, 8:50am

AAO

Verana Health showcases the VeraQ quality measures dashboard for the IRIS registry report at AAO 2021.

Addressing gaps in vision care with a wearable diagnostic platform

Addressing gaps in vision care with a wearable diagnostic platform

November 19th 2021, 8:47am

AAO

Dr Mohamed Abou Shousha discusses Heru’s wearable AI-powered diagnostic devices at AAO 2021.